Q

QED Therapeutics

0 followers

QED Therapeutics, a subsidiary of BridgeBio Pharma, is a biotechnology company focused on precision medicine for FGFR-driven disorders. QED is also evaluating infigratinib in preclinical studies for the treatment of achondroplasia. They plan to develop infigratinib in additional FGFR-driven tumor ty... Read more

Industries

Employees

11-50

Links

Org chart

Matt Outten's profile picture
Matt Outten
Chief Executive Officer
Profile photo

Matt Outten

Collapse
Rick Panicucci's profile picture
Rick Panicucci
SVP of CMC
Mike Monteith
Senior Vice President, Pharmaceutical Development, QED Therapeutics
Vanessa Solis
Senior Executive Administrator to COO
  1. Something went wrong loading the org chart, please refresh the page.